About VigiAccess
VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects of medicinal products. Side effects – known technically as adverse drug reactions (ADRs) … are reported by national pharmacovigilance centres or national drug regulatory authorities that are members of the WHO Programme for International Drug Monitoring.
Special note regarding COVID-19 vaccine data
To see VigiBase data on COVID-19 vaccines, search for “covid-19 vaccine”. Even searches for exact tradenames, such as “Comirnaty” or “Covishield”, will result in the total number of cases reported for all COVID-19 vaccines. It is not possible in VigiAccess to separate the numbers for specific vaccines.
Comment of the editorial staff of this website: Transparency??
Important points to consider
VigiAccess cannot be used to infer any confirmed link between a suspected side effect and any specific medicine. The information on this website relates to potential side effects; that is, symptoms and other circumstances that have been observed following the use of a medicinal product, but which may or may not be related to or caused by that product.
Comment of the editorial staff of this website: What is the meaning of these data then? They cannot admit that they are the effects of the “vaccinations” because then they will be liable.
Checklist for working with the database:
checklist for the VigiAccess database
